Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC

INTRODUCTION: Despite radical intent therapy for patients with stage III non-small-cell lung cancer (NSCLC), cumulative incidence of brain metastases (BM) reaches 30%. Current risk stratification methods fail to accurately identify these patients. As radiomics features have been shown to have predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Keek, Simon A., Kayan, Esma, Chatterjee, Avishek, Belderbos, José S. A., Bootsma, Gerben, van den Borne, Ben, Dingemans, Anne-Marie C., Gietema, Hester A., Groen, Harry J. M., Herder, Judith, Pitz, Cordula, Praag, John, De Ruysscher, Dirk, Schoenmaekers, Janna, Smit, Hans J. M., Stigt, Jos, Westenend, Marcel, Zeng, Haiyan, Woodruff, Henry C., Lambin, Philippe, Hendriks, Lizza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403451/
https://www.ncbi.nlm.nih.gov/pubmed/36032350
http://dx.doi.org/10.1177/17588359221116605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403451/
https://www.ncbi.nlm.nih.gov/pubmed/36032350
http://dx.doi.org/10.1177/17588359221116605

Ejemplares similares